Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8896497rdf:typepubmed:Citationlld:pubmed
pubmed-article:8896497lifeskim:mentionsumls-concept:C0021311lld:lifeskim
pubmed-article:8896497lifeskim:mentionsumls-concept:C0039194lld:lifeskim
pubmed-article:8896497lifeskim:mentionsumls-concept:C0108779lld:lifeskim
pubmed-article:8896497lifeskim:mentionsumls-concept:C0238607lld:lifeskim
pubmed-article:8896497lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:8896497lifeskim:mentionsumls-concept:C0864632lld:lifeskim
pubmed-article:8896497pubmed:issue5lld:pubmed
pubmed-article:8896497pubmed:dateCreated1996-11-27lld:pubmed
pubmed-article:8896497pubmed:abstractTextHuman immunodeficiency virus type 1 (HIV-1)-infected persons frequently have increased numbers of T cells bearing the gamma delta T cell receptor for antigen (gamma delta TCR). HIV-1-seropositive patients with < 100 CD4+ cells/mm3 were selected and divided into 9 AIDS-defining illness groups. The percentages of CD4+, CD8+, or double-negative CD4-CD8- (DN) T cells (most of the latter expressing the gamma delta TCR) for 8 symptomatic groups were compared with those for a reference group of asymptomatic HIV-1-infected patients. DN T cells were increased only in patients with disseminated Mycobacterium avium-intracellulare complex (MAC) infection, toxoplasmosis, or Kaposi's sarcoma. Multivariate logistic regression analysis revealed that the percentage of DN T cells was a better predictor of MAC infection than was the percentage of CD4+T cells. The increased percentage of DN T cells might have important implications for the understanding of gamma delta T cell physiology and for the early diagnosis and management of MAC infections in AIDS patients.lld:pubmed
pubmed-article:8896497pubmed:languageenglld:pubmed
pubmed-article:8896497pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8896497pubmed:citationSubsetAIMlld:pubmed
pubmed-article:8896497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8896497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8896497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8896497pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8896497pubmed:statusMEDLINElld:pubmed
pubmed-article:8896497pubmed:monthNovlld:pubmed
pubmed-article:8896497pubmed:issn0022-1899lld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:ConstantMMlld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:MoreauJ FJFlld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:RagnaudJ MJMlld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:BernardNNlld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:JournotVVlld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:DuponMMlld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:PellegrinJ...lld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:BarbeauPPlld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:DabisFFlld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:BonnevilleMMlld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:TaupinJ LJLlld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:Texier-Maugei...lld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:CarronJ CJClld:pubmed
pubmed-article:8896497pubmed:authorpubmed-author:MarimoutouCClld:pubmed
pubmed-article:8896497pubmed:issnTypePrintlld:pubmed
pubmed-article:8896497pubmed:volume174lld:pubmed
pubmed-article:8896497pubmed:ownerNLMlld:pubmed
pubmed-article:8896497pubmed:authorsCompleteYlld:pubmed
pubmed-article:8896497pubmed:pagination969-76lld:pubmed
pubmed-article:8896497pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:meshHeadingpubmed-meshheading:8896497-...lld:pubmed
pubmed-article:8896497pubmed:year1996lld:pubmed
pubmed-article:8896497pubmed:articleTitleIncreases in CD3+CD4-CD8- T lymphocytes in AIDS patients with disseminated Mycobacterium avium-intracellulare complex infection.lld:pubmed
pubmed-article:8896497pubmed:affiliationLaboratoire d'Immunologie, Hôpital Pellegrin, Bordeaux, France.lld:pubmed
pubmed-article:8896497pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8896497pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8896497lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8896497lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8896497lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8896497lld:pubmed